Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yindan Jiedu Granules (银丹解毒颗粒) is a Traditional Chinese Medicine (TCM) formulation developed as an in-hospital preparation by Beijing Ditan Hospital Capital Medical University. It is designed to treat viral infections by clearing heat and detoxifying (Qingre Jiedu), a standard therapeutic principle in TCM for febrile diseases. The granule is composed of several herbal extracts, including *Lonicera japonica* (honeysuckle), *Isatis tinctoria* (woad root), *Forsythia suspensa*, and *Paeonia suffruticosa*. It has been extensively used in clinical practice at Ditan Hospital for the treatment of respiratory viral diseases, including COVID-19, where it is evaluated for its efficacy in reducing symptoms and preventing the progression of mild to moderate cases in real-world medical settings.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yindan Jiedu Granules.